Filter News
Area of Research
- (-) Biology and Environment (43)
- (-) Neutron Science (29)
- Advanced Manufacturing (5)
- Biological Systems (1)
- Clean Energy (49)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (5)
- Isotope Development and Production (1)
- Isotopes (27)
- Materials (80)
- Materials for Computing (9)
- National Security (31)
- Nuclear Science and Technology (11)
- Quantum information Science (4)
- Supercomputing (49)
News Topics
- (-) Biomedical (26)
- (-) Composites (5)
- (-) Cybersecurity (1)
- (-) Isotopes (2)
- (-) Machine Learning (10)
- (-) Mercury (7)
- (-) Microscopy (13)
- (-) Physics (11)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (15)
- Advanced Reactors (2)
- Artificial Intelligence (14)
- Big Data (10)
- Bioenergy (50)
- Biology (75)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (13)
- Clean Water (13)
- Climate Change (41)
- Computer Science (31)
- Coronavirus (18)
- Critical Materials (1)
- Decarbonization (21)
- Energy Storage (13)
- Environment (97)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (4)
- Fusion (1)
- Grid (3)
- High-Performance Computing (22)
- Hydropower (8)
- Materials (25)
- Materials Science (28)
- Mathematics (3)
- Molten Salt (1)
- Nanotechnology (17)
- National Security (5)
- Net Zero (2)
- Neutron Science (99)
- Nuclear Energy (4)
- Partnerships (5)
- Polymers (3)
- Quantum Computing (1)
- Quantum Science (7)
- Renewable Energy (1)
- Security (4)
- Simulation (14)
- Summit (15)
- Sustainable Energy (32)
- Transformational Challenge Reactor (1)
- Transportation (8)
Media Contacts
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
The COHERENT particle physics experiment at the Department of Energy’s Oak Ridge National Laboratory has firmly established the existence of a new kind of neutrino interaction.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
New capabilities and equipment recently installed at the Department of Energy’s Oak Ridge National Laboratory are bringing a creek right into the lab to advance understanding of mercury pollution and accelerate solutions.